title: A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
authors.affiliation: Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California.
authors.forename: M
authors.initials: M
authors.lastname: Knoop
authors.forename: D V
authors.initials: DV
authors.lastname: Cramer
authors.forename: F C
authors.initials: FC
authors.lastname: Chapman
authors.forename: L
authors.initials: L
authors.lastname: Makowka
mesh_terms: D000818:Animals; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D051381:Rats; D011912:Rats, Inbred ACI; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D013997:Time Factors; D014184:Transplantation, Homologous; D011798:Quinaldines
chemical_list: D001713:Biphenyl Compounds; D007166:Immunosuppressive Agents; C046943:brequinar; D011798:Quinaldines